Covidien (COV)
Covidien Revenues: 2.946B
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
COV Revenues Rankings
| Overall | 92nd percentile | 328 of 4425 |
| Sector | 94th percentile | 25 of 470 in Healthcare |
| Industry | 95th percentile | 3 of 67 in Medical Instruments & Supplies |
COV Revenues Range, Past 5 Years
| Minimum | 2.269B | Jun 2007 |
| Maximum | 3.078B | Sep 2011 |
| Average | 2.650B |
About Revenues
Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity.
Learn More
You may also be interested in these COV related companies
COV News
Covidien Announces Senior Notes Offering and Redemption of 5.450% Senior Notes Due October 2012
May 22, 9:26AM Benzinga
May 22, 9:26AM Benzinga
Covidien Introduces HALO90 ULTRA Ablation Catheter for Treatment of Barrett’s Esophagus
May 17, 7:00AM Business Wire
May 17, 7:00AM Business Wire
Listen to $COV at deutsche bank ag health care conference - live at 02:50 PM, ondemand after - http://stks.co/3hlk
about 21 days ago by earningscast
about 21 days ago by earningscast
$COV Insider Sale: $1.3M of stock sold by Michael Sgrignari on May 3, 2012 http://stks.co/3gLK
about 24 days ago by MarketBrief
about 24 days ago by MarketBrief
$COV Insider Sale: $1.9M of stock sold by Bryan Hanson on May 1, 2012 http://stks.co/3dJE
about 26 days ago by MarketBrief
about 26 days ago by MarketBrief
Stocks that touched their 10 EMA from above today: $DD $PLD $LTD $COV $SLE $XLV $ITW http://stks.co/3c9g
about 27 days ago by Attitrade
about 27 days ago by Attitrade
Intrepid Investment Bankers LLC Advises Newport Medical Instruments, Inc. in its Sale to Covidien plc
May 01, 6:55PM PR Newswire
May 01, 6:55PM PR Newswire
Listen to $COV Q2 2012 earnings call - live at 08:30 AM, ondemand after - http://stks.co/3Y4F
about 32 days ago by earningscast
about 32 days ago by earningscast
$COV - Nice action on solid volume today. This one is still on breakout watch. http://chart.ly/f7q5f9l
about 32 days ago by AffluenzaVirus
about 32 days ago by AffluenzaVirus
Raymond James Starts MedTech Sector: CFN, COO, COV at Strong Buy, SLTM, ISRG, BAX at Outperform, BDX at Underperform
Apr 25, 10:00AM Street Insider
Apr 25, 10:00AM Street Insider
$HBIO to present at SeeThruEquity Small Inv Conf 6/5, Cornell Club in NYC http://stks.co/3P4h $ABT $BDX $TMO $BIO $MR $COV
about 40 days ago by ATandon_STE
about 40 days ago by ATandon_STE
Trade Ideas for the Week of April 2, 2012 http://stks.co/3AhV via @harmongreg $COV $EZPW $MSG
about 57 days ago by StockTwits
about 57 days ago by StockTwits
Top Trade Ideas for the Week of April 2, 2012: The Rest | via @harmongreg http://stks.co/3Ado $COV $EZPW $MSG $RF $TXN
about 57 days ago by STNet
about 57 days ago by STNet
Top Trade Ideas for the Week of April 2, 2012: The Rest http://stks.co/3Abk $COV $EZPW $RF $MSG $TXN, Bonus Idea in the morning
about 57 days ago by harmongreg
about 57 days ago by harmongreg
Stocks trading ex-dividend one week from today: http://stks.co/34RG $CMCSA $COV $RCII $RTN $ACU $CGI $CLI $ROMA ...
about 64 days ago by DynamicDividend
about 64 days ago by DynamicDividend
SeeThruEquity Small Cap Investor Conference: 6/5 @ the Cornell Club NYC - info and register @ http://stks.co/32jm $MRK $COV $JNJ $NVS $PFE
about 66 days ago by ATandon_STE
about 66 days ago by ATandon_STE
I'll be on @FoxBusiness w/ @LizClaman at 4:15 p.m. today to talk "crash proof healthcare stocks" $ABT $CERN $COV. Check your local listings!
about 74 days ago by JeffReevesIP
about 74 days ago by JeffReevesIP
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| COV | 53.32 | -0.14 | -0.26% | 25.77B |
| COT | 7.55 | +0.11 | +1.48% | 718.00M |
| COST | 84.48 | +0.00 | +0.00% | 36.74B |
| CTIC | 0.91 | -0.01 | -1.09% | 206.22M |
| CTHR | 3.89 | +0.03 | +0.78% | 75.66M |
| CTGX | 12.45 | +0.16 | +1.30% | 230.70M |
| CTFO | 4.55 | -0.09 | -1.94% | 114.98M |
| CTEL | 10.58 | -0.19 | -1.76% | 408.92M |
| CTCT | 20.58 | +0.12 | +0.59% | 622.13M |
| CTCM | 9.35 | -0.10 | -1.06% | 1.471B |
